ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 320 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $315 | -62.6% | 11,955 | -56.9% | 0.04% | -60.0% |
| Q1 2024 | $842 | +44.7% | 27,723 | +33.8% | 0.09% | +45.2% |
| Q4 2023 | $582 | -65.9% | 20,716 | -62.7% | 0.06% | -71.2% |
| Q2 2023 | $1,705 | +157.6% | 55,471 | +201.9% | 0.22% | +252.5% |
| Q1 2023 | $662 | -6.6% | 18,373 | +2.3% | 0.06% | -14.1% |
| Q4 2022 | $709 | -99.9% | 17,960 | -17.9% | 0.07% | -18.4% |
| Q3 2022 | $879,000 | +109.3% | 21,880 | +103.3% | 0.09% | +74.0% |
| Q1 2022 | $420,000 | +53.8% | 10,760 | +61.4% | 0.05% | +85.2% |
| Q2 2021 | $273,000 | – | 6,668 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |